Hyperbaric Oxygen Therapy (HBOT) has been used since decades to treat various chronic illnesses. This innovative therapeutic approach involves breathing pure oxygen in a pressurized chamber, allowing the bloodstream to carry higher concentrations of oxygen to the body's tissues.
While initially developed to treat conditions like decompression sickness and non-healing wounds, HBOT has shown its potential in managing the lingering symptoms of Long Covid and other chronic health issues.
The underlying principle of hyperbaric oxygen therapy lies in its ability to enhance the body's natural healing processes by increasing the supply of oxygen to damaged or inflamed tissues. This elevated oxygen level promotes tissue repair, reduces inflammation, and supports the overall recovery of bodily functions.
During gathering our clinical experience we observed that HBOT achieves better results in patients AFTER a course of H.E.L.P. Apheresis.
Current studies can be found here:
How to Evaluate Hyperbaric Oxygen Therapy for Long COVID
How Long COVID patients benefits from oxygen therapy
Phase II trial: Hyperbaric oxygen for long COVID-19
*service supplied by Panacea Medical Center
Apheresis Center, H.E.L.P. Apheresis & Combination Therapy
Featured In
Member of the Cyprus Medical Association
Dr. Irina Pavlik Marangos
Our Partners and Suppliers
Choose Your Language
Take our free Online Microclots Test!
Our diagnostic screening questionnaire is used by thousands all over the world, clinicians and patients. It gives you an clinical diagnosis on how severely you are affected by microclots, microcirculation and blood flow issues and if further investigation is meaningful.